Publications, Pharmaceutical

Aptar Pharma’s Ready-to-Use Program Facilitates Development Times

Pharma customers serving the biologics market require smaller manufacturing runs as these markets have a smaller subset of patients. As a result, contract partners must be able to provide Ready-To-Use (RTU) products that allow for faster and more flexible runs.

Download Publication
Author(s): Adam Shain
Publication: Drug Development & Delivery
1 May 2019

Pharma customers serving the biologics market require smaller manufacturing runs as these markets have a smaller subset of patients. As a result, contract partners must be able to provide Ready-To-Use (RTU) products that allow for faster and more flexible runs.
Aptar Pharma fulfills this request for customer by providing RTU stoppers. The stoppers, along with vials, and seals are available through Aptar’s QuickStart® for Injectables, a one-stop-shop, ready-to-use sterile solution, designed specifically to accelerate the development time for start-ups and early-stage development, R&D, biotechs, and university research organizations.

DOWNLOAD PUBLICATION

Start a Project With Us

We Thrive on Transforming Ideas into Opportunities – Let Yours be Next.

Contact a Pharma Expert

Back To Top